. 2023 Nov 27;24(1):2285817. doi: 10.1080/15384047.2023.2285817
© 2023 The Author(s). Published with license by Taylor & Francis Group, LLC.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
Figure 6.
High VASH1 expression resulted in a higher sensitivity to multiple drugs in ovarian cancer.